SIM
PTLA

Spark Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Spark Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-133,000
Closed -$3.14M – 919
2016
Q2 		$3.14M Sell
133,000
-8,300
-6% -$205K 0.29% 101
2016
Q1 		$2.88M Buy
+141,300
New +$4.48M 0.29% 100

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Spark Investment Management's PTLA Position: Q3 2016 in Review

Spark Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2016, closing a stake of 133,000 shares — an estimated $3.14M sold.

Spark Investment Management first reported a position in PTLA in Q1 2016 and held it in 2 quarters. The position peaked at $3.14M in Q2 2016. 151 funds tracked by Wall St. Rank hold PTLA as of Q3 2016.

  • Spark Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Spark Investment Management sold 133,000 Portola Pharmaceuticals, Inc. shares in Q3 2016, an estimated $3.14M.
  • Spark Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2016 and held it in 2 quarters.
  • Spark Investment Management's Portola Pharmaceuticals, Inc. position peaked at $3.14M in Q2 2016.
  • 151 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2016.

Based on Spark Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.